Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Health Secur ; 15(2): 170-174, 2017.
Article in English | MEDLINE | ID: mdl-28418743

ABSTRACT

The Taiwan Centers for Disease Control (Taiwan CDC) has established a 3-tier personal protective equipment (PPE) stockpiling framework that could maintain a minimum stockpile for the surge demand of PPE in the early stage of a pandemic. However, PPE stockpiling efforts must contend with increasing storage fees and expiration problems. In 2011, the Taiwan CDC initiated a stockpile replacement model in order to optimize the PPE stockpiling efficiency, ensure a minimum stockpile, use the government's limited funds more effectively, and achieve the goal of sustainable management. This stockpile replacement model employs a first-in-first-out principle in which the oldest stock in the central government stockpile is regularly replaced and replenished with the same amount of new and qualified products, ensuring the availability and maintenance of the minimum stockpiles. In addition, a joint electronic procurement platform has been established for merchandising the replaced PPE to local health authorities and medical and other institutions for their routine or epidemic use. In this article, we describe the PPE stockpile model in Taiwan, including the 3-tier stockpiling framework, the operational model, the components of the replacement system, implementation outcomes, epidemic supports, and the challenges and prospects of this model.


Subject(s)
Models, Theoretical , Personal Protective Equipment/supply & distribution , Strategic Stockpile/economics , Humans , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Influenza, Human/transmission , Pandemics/economics , Personal Protective Equipment/statistics & numerical data , Respiratory Protective Devices , Taiwan
2.
Mater Sci Eng C Mater Biol Appl ; 42: 385-95, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25063132

ABSTRACT

Nb-60Ta-2Zr is a newly developed MRI-compatible alloy used for vascular stents. In this work, its haemocompatibility was investigated, including platelet adhesion (lactate dehydrogenase activity), platelet activation (P-selectin expression), coagulation and haemolysis. For comparison, parallel assessments for these factors were performed for the niobium, tantalum, 316L stainless steel (316L SS) and L605 Co-Cr alloy (L605). In addition, albumin and fibrinogen were selected to examine the correlation of protein adsorption with platelet adhesion and metal surface properties. The propensity for platelet adhesion and activation on the Nb-60Ta-2Zr alloy was at nearly the same level as that for Nb and Ta but was slightly less than those of 316L SS and L605. The mitigated platelet adhesion and activation of the Nb-60Ta-2Zr alloy is associated with its decreased adsorption of fibrinogen. The Nb-60Ta-2Zr alloy has a longer clotting time and exhibits significantly superior thromboresistance than 316L SS and L605. Moreover, the haemolysis rate of the Nb-60Ta-2Zr alloy satisfies the bio-safety requirement of the ISO 10993-4 standard. The favourable haemocompatiblity of the Nb-60Ta-2Zr alloy provides evidence of its good biocompatibility and of its suitability as a candidate stent material.


Subject(s)
Alloys/chemistry , Biocompatible Materials/chemistry , Hemolysis/drug effects , Niobium/chemistry , Stents , Zirconium/chemistry , Adsorption , Alloys/pharmacology , Alloys/toxicity , Biocompatible Materials/pharmacology , Biocompatible Materials/toxicity , Blood Vessel Prosthesis , Humans , Magnetic Resonance Imaging , Materials Testing , Niobium/pharmacology , Niobium/toxicity , Platelet Activation/drug effects , Platelet Adhesiveness/drug effects , Zirconium/pharmacology , Zirconium/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...